DK0556322T3 - Aminosulfonylurinstof-ACAT-inhibitorer - Google Patents

Aminosulfonylurinstof-ACAT-inhibitorer

Info

Publication number
DK0556322T3
DK0556322T3 DK92900981.9T DK92900981T DK0556322T3 DK 0556322 T3 DK0556322 T3 DK 0556322T3 DK 92900981 T DK92900981 T DK 92900981T DK 0556322 T3 DK0556322 T3 DK 0556322T3
Authority
DK
Denmark
Prior art keywords
acat inhibitors
compounds
aminosulfonylurinstof
useful
aminosulfonyl
Prior art date
Application number
DK92900981.9T
Other languages
Danish (da)
English (en)
Inventor
Joseph Armand Picard
Drago Robert Sliskovic
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Application granted granted Critical
Publication of DK0556322T3 publication Critical patent/DK0556322T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
    • C07D211/96—Sulfur atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C307/00—Amides of sulfuric acids, i.e. compounds having singly-bound oxygen atoms of sulfate groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C307/04—Diamides of sulfuric acids
    • C07C307/06—Diamides of sulfuric acids having nitrogen atoms of the sulfamide groups bound to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C307/00—Amides of sulfuric acids, i.e. compounds having singly-bound oxygen atoms of sulfate groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C307/04—Diamides of sulfuric acids
    • C07C307/08—Diamides of sulfuric acids having nitrogen atoms of the sulfamide groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C307/00—Amides of sulfuric acids, i.e. compounds having singly-bound oxygen atoms of sulfate groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C307/04—Diamides of sulfuric acids
    • C07C307/10—Diamides of sulfuric acids having nitrogen atoms of the sulfamide groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/14—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK92900981.9T 1990-11-07 1991-11-05 Aminosulfonylurinstof-ACAT-inhibitorer DK0556322T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61028790A 1990-11-07 1990-11-07
US07/747,040 US5214206A (en) 1990-11-07 1991-08-19 Aminosulfonyl urea acat inhibitors

Publications (1)

Publication Number Publication Date
DK0556322T3 true DK0556322T3 (da) 1996-10-14

Family

ID=27086230

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92900981.9T DK0556322T3 (da) 1990-11-07 1991-11-05 Aminosulfonylurinstof-ACAT-inhibitorer

Country Status (16)

Country Link
US (2) US5214206A (ja)
EP (1) EP0556322B1 (ja)
JP (2) JP3256541B2 (ja)
AT (1) ATE139226T1 (ja)
AU (1) AU657928B2 (ja)
CA (1) CA2094806C (ja)
DE (1) DE69120287T2 (ja)
DK (1) DK0556322T3 (ja)
ES (1) ES2088128T3 (ja)
GR (1) GR3020355T3 (ja)
IE (1) IE75379B1 (ja)
MX (1) MX9101958A (ja)
NZ (1) NZ240481A (ja)
PH (1) PH30665A (ja)
PT (1) PT99435B (ja)
WO (1) WO1992008694A1 (ja)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT68721A (en) * 1990-12-28 1995-07-28 Teijin Ltd Benzofuran and benzizoxazole derivatives, pharmaceutical composition containing said compounds as active agent and process for preparing them
US5576335A (en) * 1994-02-01 1996-11-19 Nisshin Flour Milling Co., Ltd. Urea derivatives and their use as ACAT inhibitors
US5491170A (en) * 1994-12-19 1996-02-13 Warner-Lambert Company β-carboxy sulfonamide ACAT inhibitors
US6103733A (en) * 1998-09-09 2000-08-15 Bachmann; Kenneth A. Method for increasing HDL cholesterol levels using heteroaromatic phenylmethanes
CA2369967A1 (en) * 2001-02-12 2002-08-12 Joseph Anthony Cornicelli Methods of treating nuclear factor-kappa b mediated diseases and disorders
EP1281399A3 (en) * 2001-08-01 2004-02-11 Warner-Lambert Company Dual inhibitors of wax ester and cholesteryl ester synthesis for inhibiting sebum production
CA2818336C (en) 2010-11-16 2018-04-24 Texas Heart Institute Agonists that enhance binding of integrin-expressing cells to integrin receptors
CN103288749A (zh) * 2013-03-04 2013-09-11 盐城工学院 可作除草剂的氨基磺酰脲类化合物
WO2016053107A1 (en) * 2014-10-03 2016-04-07 Synaffix B.V. Sulfamide linker, conjugates thereof, and methods of preparation
IL273065B2 (en) * 2015-02-16 2024-01-01 Univ Queensland Sulfonylureas and related compounds and their uses
EP3416948B1 (en) * 2016-02-16 2024-07-24 The University Of Queensland Indacene bearing sulfonylureas as anti-inflammatory agents
CN110914256A (zh) 2017-07-07 2020-03-24 英夫拉索姆有限公司 新颖磺酰胺羧酰胺化合物
GB201721185D0 (en) * 2017-12-18 2018-01-31 Nodthera Ltd Sulphonyl urea derivatives
MA53221A (fr) * 2018-08-15 2022-04-27 Inflazome Ltd Nouveaux composés de sulfonamide urée
US12054461B2 (en) 2019-06-12 2024-08-06 NodThera Limited Sulfonylurea derivatives and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2312404A (en) * 1939-11-22 1943-03-02 Haack Erich Method of preparing n-sulphonylureas
CH396872A (de) * 1959-08-13 1965-08-15 Ciba Geigy Verfahren zur Herstellung neuer Harnstoffe
US3242174A (en) * 1962-02-06 1966-03-22 Pfizer & Co C 1-(tertiary aminosulfonyl)-3-(hydrocarbon) ureas
GB990860A (en) * 1962-02-08 1965-05-05 Pfizer & Co C N,n-disubstituted sulfamylureas and compositions thereof
US3245982A (en) * 1962-03-27 1966-04-12 Pfizer & Co C Sulfamylsemicarbazides
DE1518541A1 (de) * 1965-03-16 1969-09-11 Boehringer Mannheim Gmbh Verfahren zur Herstellung von Sulfonylharnstoffen und Sulfonylsemicarbaziden
CH649081A5 (de) * 1982-01-12 1985-04-30 Ciba Geigy Ag Triaza-verbindungen.

Also Published As

Publication number Publication date
NZ240481A (en) 1994-06-27
IE75379B1 (en) 1997-09-10
JP3256541B2 (ja) 2002-02-12
CA2094806A1 (en) 1992-05-08
JPH06501707A (ja) 1994-02-24
US5214206A (en) 1993-05-25
AU8959791A (en) 1992-06-11
DE69120287T2 (de) 1996-10-10
ES2088128T3 (es) 1996-08-01
WO1992008694A1 (en) 1992-05-29
CA2094806C (en) 2004-11-02
ATE139226T1 (de) 1996-06-15
AU657928B2 (en) 1995-03-30
MX9101958A (es) 1992-07-08
PT99435A (pt) 1992-12-31
JP2001026574A (ja) 2001-01-30
EP0556322A1 (en) 1993-08-25
PH30665A (en) 1997-09-16
GR3020355T3 (en) 1996-09-30
PT99435B (pt) 1999-04-30
US5288757A (en) 1994-02-22
IE913874A1 (en) 1992-05-20
EP0556322B1 (en) 1996-06-12
DE69120287D1 (en) 1996-07-18

Similar Documents

Publication Publication Date Title
TR199901172T2 (xx) Yeni ikame edilmi� pirazol t�revleri.
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
EE03969B1 (et) (Metüülsulfonüül)fenüül-2-(5H)-furanoonid, nende kasutamine ja farmatseutilised kompositsioonid
TR199801255T2 (xx) Vitronektin resept�r antagonistleri.
EE9800223A (et) Fenantridiinid, neid sisaldavad ravimid ja nende kasutamine
BG46598A3 (en) Method for preparation of alpha- heterocyclic substituted tolunitriles
NO971889L (no) Forbindelser og sammensetninger for levering av aktive midler
ATE216590T1 (de) Arzneimittelformulierungen für il-12
ATE231872T1 (de) Thiazolopyrimidinderivate
ATE255589T1 (de) Kristallin form i von clarithromycin
DK0725779T3 (da) Hidtil ukendte (R)-5-Carbamoyl-8-fluor-3-N,N-disubstitueret-amino-3,4-dihydro-2H-1-benzopyraner
DK1039912T3 (da) Angiostatiske midler og præparater til behandling af GLC1A-glaukom
DK0556322T3 (da) Aminosulfonylurinstof-ACAT-inhibitorer
DK0902789T3 (da) Androstenderivater
ATE240303T1 (de) 1,2,4-triazol-3-thion verbindungen
DE69102704D1 (de) Orales, melatonin enthaltendes arzneimittel.
ATE213233T1 (de) Substituierte caprolactame und deren derivate verwendbar zur behandlung der hiv-krankheit
ATE28188T1 (de) Antikonvulsive mittel.
DK0720597T3 (da) Triarylethylenderivater til terapeutisk anvendelse
PT1232173E (pt) Derivados do acido fusidico
IT1255678B (it) Composizioni farmaceutiche per la somministrazione di paratormone, suoi frammenti biologicamente attivi o peptidi correlati per via rettale.